HUTCHMED (China) Limited (HCM)

HUTCHMED (China) Revenue

HUTCHMED (China) had revenue of $278.29M in the half year ending June 30, 2026, a decrease of -8.96%. This brings the company's total for the last twelve months to $549.12M, down -8.81% year-over-year. In the year 2025, HUTCHMED (China) had annual revenue of $548.51M, down -12.96%.

• Revenue (ttm): $549.12M
• Revenue Growth: -8.81%
• P/S Ratio: 4.65
• Revenue / Employee: $306,772
• Employees: 1,790
• Market Cap: 2.56B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Other Ventures 262.97M 47.9%
• Oncology/Immunology - Marketed Products 214.36M 39.1%
• Oncology/Immunology - R&D 71.18M 13.0%

By Geography

Chart

• People's Republic of China (PRC) 407.45M 74.3%
• U.S. and Others 141.06M 25.7%

Fiscal year ended Dec 31, 2025 See the full HUTCHMED (China) breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	548.51M	-81.69M	-12.96%
Dec 31, 2024	630.20M	-207.80M	-24.80%
Dec 31, 2023	838.00M	411.59M	96.52%
Dec 31, 2022	426.41M	70.28M	19.73%
Dec 31, 2021	356.13M	128.15M	56.21%
Dec 31, 2020	227.98M	23.09M	11.27%
Dec 31, 2019	204.89M	-9.22M	-4.31%
Dec 31, 2018	214.11M	-27.09M	-11.23%
Dec 31, 2017	241.20M	25.12M	11.63%
Dec 31, 2016	216.08M	37.88M	21.25%
Dec 31, 2015	178.20M	90.87M	104.06%
Dec 31, 2014	87.33M	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Nov 7, 2026

Data Sources Report a data error